Market revenue in 2023 | USD 2.0 million |
Market revenue in 2030 | USD 3.4 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 60% in 2023. Horizon Databook has segmented the UAE clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
The clinical research sector in the UAE is performing well, with many pharmaceutical companies investing in studies. For instance, in December 2021, AstraZeneca and G42 Healthcare partnered to expand research & diagnostics in the UAE.
The companies would focus on gathering real-world information and conducting clinical studies through G42 Healthcare's CRO. Phase III and IV studies are most common in the UAE, along with observational studies.
This is expected to improve the demand for patient recruitment services in the country and, thus, support the UAE market. Moreover, the time for approval ranges from 30 days to 90 days. The increasing number of clinical trials and growing investments by companies in R&D are likely to support the growth of the UAE market.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into UAE clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account